This company has been marked as potentially delisted and may not be actively trading. Cerevel Therapeutics (CERE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 2 at 4:00 PM | globenewswire.comLowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmApril 29 at 10:09 AM | globenewswire.comCERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmApril 29 at 9:41 AM | prnewswire.comCERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud LawsuitApril 28, 2025 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CEREApril 28, 2025 | globenewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel TherapeuticsApril 26, 2025 | globenewswire.comROSEN, A TOP RANKED LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. ...April 25, 2025 | gurufocus.comROSEN, A TOP RANKED LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CEREApril 25, 2025 | globenewswire.comCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 25, 2025 | globenewswire.comLowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmApril 25, 2025 | globenewswire.comCERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud LawsuitApril 22, 2025 | prnewswire.comROSEN, A LEADING NATIONAL FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CEREApril 22, 2025 | globenewswire.comLowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmApril 21, 2025 | globenewswire.comCerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations -- Investors Should ...April 19, 2025 | gurufocus.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. ...April 19, 2025 | gurufocus.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CEREApril 18, 2025 | globenewswire.comCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 18, 2025 | globenewswire.comLowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmApril 18, 2025 | globenewswire.comLOWEY DANNENBERG, P.C. is Investigating Claims on Behalf of California Cryobank LLC Customers Who May Have Been Harmed by a Recent Data BreachApril 18, 2025 | globenewswire.comLowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmApril 18, 2025 | globenewswire.comRobbins LLP Reminds CERE Stockholders With Large Losses to Contact the Firm for Information About the Class Action Lawsuit on Behalf of Former Cerevel Therapeutics Holdings, Inc. ShareholdersApril 16, 2025 | globenewswire.comCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 16, 2025 | prnewswire.comCERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud LawsuitApril 15, 2025 | prnewswire.comCERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmApril 14, 2025 | prnewswire.comLowey Dannenberg Notifies Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmApril 14, 2025 | globenewswire.comLowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmApril 14, 2025 | globenewswire.comCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 11, 2025 | globenewswire.comCERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmApril 11, 2025 | prnewswire.comCEREVEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cerevel Therapeutics Holdings, Inc. and Encourages Investors to Contact the FirmApril 10, 2025 | globenewswire.comRosen Law Firm Urges Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Stockholders to Contact the Firm for Information About Their RightsApril 9, 2025 | businesswire.comRosen Law Firm Urges Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Stockholders to Contact the Firm for Information About Their RightsApril 9, 2025 | businesswire.comCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 8, 2025 | prnewswire.comCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 8, 2025 | prnewswire.comCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 6, 2025 | globenewswire.comInvestor Alert: Robbins LLP Informs Stockholders of the Cerevel Therapeutics Holdings, Inc. Class ActionApril 4, 2025 | prnewswire.comEntwistle & Cappucci LLP is Investigating Potential Federal Securities Law Violations in Connection with Cerevel Therapeutics Holdings, Inc. (CERE)March 31, 2025 | businesswire.comCeres Power Holdings GAAP EPS of -14.64p, revenue of £51.89M; initiates FY25 outlookMarch 21, 2025 | seekingalpha.comCeres Power Holdings: Resilient Financial Performance and Positive Outlook Justify Buy RatingMarch 21, 2025 | tipranks.comBig Pharma Walked Away From Mental Health. Why Some Are Coming Back.March 14, 2025 | msn.comCeres Power Confirms Total Voting Rights as of February 2025February 28, 2025 | tipranks.comCeres Power Announces Total Voting Rights UpdateFebruary 28, 2025 | tipranks.comThe Vistria Group Announces the Appointment of Healthcare Pioneer Dr. Tony Coles as Senior AdvisorFebruary 20, 2025 | finance.yahoo.comCeres stock tumbles after Bosch ends partnershipFebruary 20, 2025 | investing.comOptimistic Buy Rating for Ceres Power Holdings Amid Bosch Partnership ChangesFebruary 20, 2025 | tipranks.comCeres Power Maintains Confidence as Bosch Ends PartnershipFebruary 20, 2025 | tipranks.comCeres Global Ag GAAP EPS of -$0.01, revenue of $219.9MFebruary 13, 2025 | seekingalpha.comCERE Investors Have Opportunity to Join Cerevel Therapeutics Holdings, Inc. Fraud Investigation with the Schall Law FirmFebruary 13, 2025 | prnewswire.comCERE Investors Have Opportunity to Join Cerevel Therapeutics Holdings, Inc. Fraud Investigation with the Schall Law FirmFebruary 12, 2025 | businesswire.comParkinson’s Disease Market is anticipated to Grow at a CAGR of 5.8% During the Study Period (2020-2034) by DelveInsightFebruary 8, 2025 | theglobeandmail.comAstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trialFebruary 7, 2025 | msn.com Get Cerevel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter. Email Address CERE Media Mentions By Week CERE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERE News Sentiment▼0.000.83▲Average Medical News Sentiment CERE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERE Articles This Week▼83▲CERE Articles Average Week Get Cerevel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CNX Resources News Today Core Natural Resources News Today Warrior Met Coal News Today Hallador Energy News Today Beigene News Today Royalty Pharma News Today Summit Therapeutics News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Genmab A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERE) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerevel Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerevel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CERE Stock Free CERE Stock Alerts